The TRUTH About the "Best Time" to Take PROBIOTICS (RESEARCH PAPERS) - YouTube
Follow for more: https://www.instagram.com/drbenlynch/When is the best time to take probiotics? Dr. Ben Lynch is a bestselling author (Dirty Genes), a natur...
Gastroenterologist and microbiome expert Dr. Sabine Hazan reveals that many commercial yogurts and probiotics don’t contain the gut-healthy strains they claim, raising major concerns about the yogurt and supplement industry standards. Her cutting-edge research links gut health to chronic disease and vaccine response, pointing to the microbiome as a critical—yet overlooked—piece of the medical puzzle. […]
This New Theory Could Change Microbiology Forever - Dr. Joe Francis - YouTube
What if tiny viruses are doing more than just invading your body—what if they're actually protecting you? In this groundbreaking presentation, microbiologist...
Nitazoxanide: A first-in-class broad-spectrum antiviral agent - PMC
Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. A Phase 2b/3 clinical trial recently published ...
The Dr Ardis Show | Are you allergic? Food Allergies with Dr. Ealy | Episode 05.08.2024
In this podcast episode, Dr. Henry Ealy and Dr. Brian Ardis discuss the impact of food allergies on health. Dr. Ealy shares his personal experience with delayed food allergies and the surprising resul
Male Fertility and the Semen Microbiome - David Perlmutter M.D.
It seems as if there is no limit to the various body systems that are now being characterized as having a unique association with bacteria and other resident living organisms. …
No More Waking Up To Pee at Night! | Dr. Steven Gundry - YouTube
Are you tired of being constantly interrupted during your precious sleep by those annoying trips to the bathroom? Well, you're not alone! In this video, we'r...
Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals | ACS Chemical Biology
Recent advances in sequencing techniques unveiled the vast potential of ribosomally synthesized and post-translationally modified peptides (RiPPs) encoded in microbiomes. Class I lantibiotics such as nisin A, widely used as a food preservative, have been investigated for their efficacy in killing pathogens. However, the impact of nisin and nisin-like class I lantibiotics on commensal bacteria residing in the human gut remains unclear. Here, we report six gut-derived class I lantibiotics that are close homologues of nisin, four of which are novel. We applied an improved lantibiotic expression platform to produce and purify these lantibiotics for antimicrobial assays. We determined their minimal inhibitory concentration (MIC) against both Gram-positive human pathogens and gut commensals and profiled the lantibiotic resistance genes in these pathogens and commensals. Structure–activity relationship (SAR) studies with analogs revealed key regions and residues that impact their antimicrobial properties. Our characterization and SAR studies of nisin-like lantibiotics against both pathogens and human gut commensals could shed light on the future development of lantibiotic-based therapeutics and food preservatives.
After a century of nisin research - where are we now? | FEMS Microbiology Reviews | Oxford Academic
The highly post-translationally modified peptide nisin has been studied over the course of the last 100 years, and although it has been employed successfully as